Exclusive—Chad F. Wolf: Close the Chinese Drug Back Door, Bring Medicine Production Back to the U.S.

America’s dependence on foreign drug ingredients is a national security and safety issue that is hiding in plain sight.

For years, Washington outsourced the very building blocks of our medicines to cut-rate producers abroad, especially in China. That was a bargain with fine print: quality we can’t verify, leverage we don’t control, and risks that land directly in American veins. The Trump administration was right to call this out and push for a tougher line on Chinese Communist Party (CPP) leadership and strategic decoupling.

Now we need to finish the job by rebuilding U.S. manufacturing and shutting the loopholes that let unsafe products slip through.

Popular and common weight-loss drugs are a prime example. They show both the promise and peril. But the weight-loss boom has opened a ba